TBA Law Blog


Posted by: Azya Thornton on May 7, 2025

The Department of Justice (DOJ) on Monday said a lawsuit against the Food and Drug Administration (FDA) seeking to restrict the abortion pill mifepristone should be dismissed for lack of standing. In a court filing, the DOJ argued that Idaho, Missouri and Kansas have no ties to Amarillo, Texas, where the lawsuit was filed, and that the states are free to file in their own districts, The Hill reports. The states did not file their own lawsuit but were instead granted the ability to intervene in a lawsuit filed by private parties in 2022. The states argue that some of the FDA’s actions to loosen access to mifepristone allowed the pills to flood across their borders, undermining their anti-abortion laws. Last year, the Supreme Court dismissed the original plaintiffs' suit, ruling that private parties had no legal standing to challenge access to the drug.